South San Francisco

10–100 Companies
Companies
54
Growing
Deals 2019 Q4
2 investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Xconomy

Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...

$15,000,000 Venture capital (Series B)
the home of AI info , the home of AI info

Business Briefs: Cytovale Announces $15 Million in Financing

the home of AI info

Roche/Genentech Partnering Team: One Face For The World To See

Xconomy

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

MedCity News

Drug-discovery firm nets $14.5M in Series A funding

GeekWire

Jeff Bezos-backed vertical agriculture startup Plenty ‘hibernates’ plans for Seattle farm

$14,500,000 Venture capital (Series A)
FinSMEs

X-37 Raises $14.5M in Series A Funding

the home of AI info

Genentech's Risdiplam Meets Primary Endpoint in Pivotal SUNFISH Trial in People With Type 2 or ...

VCCircle

Cipla acquires rights for a prescription drug from bankrupt US firm Achaogen

Xconomy

Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery

MedCity News

Cytokinetics remains positive on negative Phase II reldesemtiv study in ALS

Xconomy

Xconomy: Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval

$100,000,000 Venture capital (Series D)
PE HUB

Kinestral lands over $100 mln Series D

FinSMEs

Kinestral Technologies Secures Over $100M in Series D Funding

MedCity News

Veracyte partners with J&J on development of lung cancer test

Xconomy

MyoKardia Goes Solo as Sanofi Ends Precision Heart Drug Deal

MedCity News

Preclinical startup Jecure makes bee-line to exit with Genentech buyout

Acquisition
FinSMEs

Genentech Acquires Jecure Therapeutics